Why is it so important to rank the top 100 in the medical device industry in 2017?
There have always been questions about the ranking of medical device companies in the industry, why do they rank every year? Don't people in the industry know which are the industry leaders? Will these rankings change greatly from year to year? In fact, this ranking can reveal the trend of the medical device industry, which is equivalent to the annual weather vane of medical industry technology.
Here are some thoughts on this year's top 100:
1 、M & A frenzy continues
Mergers and acquisitions continue to change the size of the medical device industry, as shown in our rankings. For example, Medtronic PLC's top 100 position is largely due to its $50 trillion acquisition of Kehui Medical in 2015, which pushed Johnson & Johnson's medical devices sector into second place. Jaime Bangmei's ranking rose to 15th this year, up from 19 last year, thanks to Jaime's acquisition of Bangmei in 2015. After the acquisition of the clinical microbiology business of Siemens Medical Diagnostics, Dana shifted its focus to the life sciences, jumping from 13th to eighth this year.
As a result of mergers and acquisitions, we can also predict some changes in the top 100 ranking of medical devices in 2018. For example, Abbott Laboratories completed the acquisition of St. Joda Medical Company for $25 trillion. At the same time, in July this year, Kangdelle bought Medtronic PLC's patient care, deep venous thrombosis and malnutrition business for $6.1 billion.
2 、Not just mergers and acquisitions.
Spin-off and spin-off are also part of mergers and acquisitions. Intergla Life Sciences, for example, transformed its chiropractic category in 2015, renamed Seaspine, and made its debut this year in 99th place.
3 、When the river rises, the boat floats high
The merger has another impact on our list: the expansion brought about by the merger has made some marginal companies in the top 100 for the first time.
4 、Innovation promotes development
Medical device companies have no particularly strong need to be at the top of the list. In the case of NxStage Healthcare and his home hemodialysis system, NxStage rose from 97 last year to 88 this year, probably because it was in the process of being acquired by Goffenius (fifth this year).
In terms of ranking, Medtronic PLC took the top spot with $29.7 billion, while the 100th place had sales of $120 million. The specific rankings are as follows:
1-10
Medtronic PLC, Johnson & Johnson, Philips, GE Medical, Fresenius, Siemens Medical, Kandler, Danaher Corp, Stryker Corp, Baxter
11-20
Omex-McNone, Bidi, Boston Science, Eye Road, Jaime Bangmei, Belang, Alcon, 3M Company, Olympus, Abbott Laboratories,
20-30
Termao, Smith, Dunsberg, Bud, Fuji Images, Jiedin, Varian, Edward, tag Heuer, Holloguet
Big 100 2017: Medtech's 100 Largest Players
